In active renal disease patients, the IL-1β levels were positively correlated with SLEDAI score (r = 0.33, P < 0.001) compared with TNF-α (r = 0.18, P = 0.001) and IL-6 (r = 0.11, P = 0.01). Here, IL6 is linked to kidney disorder.